Placebo Surgery for Parkinson's Disease: Do the Benefits Outweigh the Risks?
Journal of Law, Medicine and Ethics 30 (1):58-68 (2002)
| Abstract | This article has no associated abstract. (fix it) | |||||||||
| Keywords | No keywords specified (fix it) | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
Download options| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,701 |
| External links |
 |
| Through your library | Configure |
Similar books and articlesTeresa Swift & Richard Huxtable (2013). The Ethics of Sham Surgery in Parkinson's Disease: Back to the Future? Bioethics 27 (4):175-185.
Raúl de la Fuente-Fernández & A. Jon Stoessl (2004). The Biochemical Bases of the Placebo Effect. Science and Engineering Ethics 10 (1).
Z. Master, M. McLeod & I. Mendez (2007). Benefits, Risks and Ethical Considerations in Translation of Stem Cell Research to Clinical Applications in Parkinson's Disease. Journal of Medical Ethics 33 (3):169-173.
R. L. Albin (2002). Sham Surgery Controls: Intracerebral Grafting of Fetal Tissue for Parkinson's Disease and Proposed Criteria for Use of Sham Surgery Controls. Journal of Medical Ethics 28 (5):322-325.
Georg Spielthenner (forthcoming). Risk-Benefit Analysis: From a Logical Point of View. Journal of Bioethical Inquiry (Browse Results).
John Appiah-Poku, Sam Newton & Nancy Kass (2011). Participants' Perceptions of Research Benefits in an African Genetic Epidemiology Study. Developing World Bioethics 11 (3):128-135.
Franklin G. Miller (2004). Sham Surgery: An Ethical Analysis. Science and Engineering Ethics 10 (1):41-48.
Benjamin Seltzer, Jennifer J. Vasterling, Charles W. Mathias & Angela Brennan (2001). Clinical and Neuropsychological Correlates of Impaired Awareness of Deficits in Alzheimer Disease and Parkinson Disease: A Comparative Study. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 14 (2):122-129.
Caspar Hare (2009). The Ethics of Morphing. Philosophical Studies 145 (1):111 - 130.
Bernhard Bogerts (2002). Does Catatonia Have a Specific Brain Biology? Behavioral and Brain Sciences 25 (5):580-581.
David B. Resnik (2012). Ethical Issues in Field Trials of Genetically Modified Disease-Resistant Mosquitoes. Developing World Bioethics 12 (3).
den Bosch & M. P. (2005). Structures in Neuropharmacology. Poznan Studies in the Philosophy of the Sciences and the Humanities 84 (1):343-359.
Irwin Savodnik (2002). The Disease Status of Catatonia. Behavioral and Brain Sciences 25 (5):590-591.
Analytics
Monthly downloads |
Added to index2010-08-31Total downloads3 ( #202,008 of 549,113 )Recent downloads (6 months)0How can I increase my downloads? |
My notes
Discussion
